Myostatin mediates abdominal aortic atherosclerosis progression by inducing vascular smooth muscle cell dysfunction and monocyte recruitment

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Verzola, D ^a   Milanesi, S ^a   Bertolotto, M ^a   Garibaldi, S ^b   Villaggio, B ^a   Brunelli, C ^b   Balbi, M ^b   Ameri, P ^b   Montecucco, F ^a,b   Palombo, D ^c   Ghigliotti, G ^b   Garibotto, G ^a   Lindeman, J H ^d   Barisione, C ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTA2 PROTEIN, HUMAN; ACTIN; CYTOSKELETON PROTEIN; MSTN PROTEIN, HUMAN; MUSCLE PROTEIN; MYOSTATIN; SMTN PROTEIN, HUMAN;

ABDOMINAL AORTA; ANIMAL; ATHEROSCLEROSIS; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; DISEASE EXACERBATION; GENETICS; HUMAN; METABOLISM; MONOCYTE; RAT; THP-1 CELL LINE; VASCULAR SMOOTH MUSCLE;

ACTINS; ANIMALS; AORTA, ABDOMINAL; ATHEROSCLEROSIS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CYTOSKELETAL PROTEINS; DISEASE PROGRESSION; HUMANS; MONOCYTES; MUSCLE PROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOSTATIN; RATS; THP-1 CELLS;

EID: 85017452303     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep46362     Document Type: Article

References (56)

1. Ross, R. Atherosclerosis-An Inflammatory Disease. N Engl J Med. 340, 115-126 (1999).
2. Lusis, A. J. Atherosclerosis. Nature. 407, 233-241 (2000).
3. Randolph, G. J. The fate of monocytes in atherosclerosis. J Thromb Haemost. 7, 28-30 (2009).
4. Libby, P., Ridker, P. M., Hansson, G. K. Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: From pathophysiology to practice. J Am Coll Cardiol. 54, 2129-2138 (2009).
5. Rateri, D. L., et al. Prolonged infusion of angiotensin II in apoEmice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysm. Am J Pathol. 179, 1542-1548 (2011).
6. Leeper, N. J., et al. Apelin prevents aortic aneurysm formation by inhibiting macrophage inflammation. Am J Physiol Heart Circ Physiol. 296, H1329-H1335 (2009).
7. Owens, G. K., Kumar, M. S., Wamhoff, B. R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease Physiol. Rev. 84, 767-801 (2004).
8. Nguyen, A. T., et al. Smooth muscle cell plasticity: Fact or fiction Circ Res. 112, 17-22 (2013).
9. Crosas-Molist, E., et al. Vascular smooth muscle cell phenotypic changes in patients with Marfan syndrome. Arterioscler Thromb Vasc Biol. 35, 960-972 (2015).
10. Spinetti, G., et al. Rat aortic MCP-1 and its receptor CCR2 increase with age and alter vascular smooth muscle cell function. Arterioscler Thromb Vasc Biol. 24, 1397-1402 (2004).
11. Wang, M., et al. A local proinflammatory signalling loop facilitates adverse age-associated arterial remodeling. PLoS One 6, e16653 (2011).
12. De Keulenaer, G. W., et al. Convergence of redox-sensitive and mitogen-activated protein kinase signaling pathways in tumor necrosis factor-alpha-mediated monocyte chemoattractant protein-1 induction in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 20, 385-91 (2000).
13. Zhou, D., et al. Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways. Cell Signal. 26, 192-197 (2014).
14. Satonaka, H., et al. Involvement of P2Y12 receptor in vascular smooth muscle inflammatory changes via MCP-1 upregulation and monocyte adhesion. Am J Physiol Heart Circ Physiol. 308, H853-H861 (2015).
15. McPherron, A. C., Lawler, A. M., Lee, S. J. Regulation of skeletal muscle mass in mice by a new TGF-superfamily member. Nature. 387, 83-90 (1997).
16. Shaoquan, J., et al. Myostatin expression in porcine tissues: Tissue specificity and developmental and postnatal regulation. Am J Physiol Regul Integr Comp Physiol. 275, R1265-R1273 (1998).
17. Dschietzig, T. B. Myostatin-From the Mighty Mouse to cardiovascular disease and cachexia. Clin Chim Acta, 433, 216-224 (2014).
18. Rodgers, B. D., et al. Myostatin represses physiological hypertrophy of the heart and excitation-contraction coupling. J Physiol. 587, 4873-4886 (2009).
19. Fernández-Solà, J., Borrisser-Pairó, F., Antúnez, E., Tobiás E. Myostatin and insulin-like growth factor-1 in hypertensive heart disease: A prospective study in human heart donors. J Hypertens. 33, 851-858 (2015).
20. Castillero, E., et al. Cardiac myostatin upregulation occurs immediately after myocardial ischemia and is involved in skeletal muscle activation of atrophy. Biochem Biophys Res Commun. 457, 106-111 (2015).
21. Heineke, J., et al. Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure. Circulation. 121, 419-425 (2010).
22. Han, H. Q., Zhou, X., Mitch, W. E., Goldberg A. L. Myostatin/activin pathway antagonism: Molecular basis and therapeutic potential. Int J Biochem Cell Biol. 45, 2333-2347 (2013).
23. Guo, W., Wong, S., Bhasin, S. AAV-mediated administration of myostatin pro-peptide mutant in adult Ldlr null mice reduces dietinduced hepatosteatosis and arteriosclerosis. PLoS One. 8, e71017 (2013).
24. Tu, P., et al. Genetic disruption of myostatin reduces the development of proatherogenic dyslipidemia and atherogenic lesions in Ldlr null mice. Diabetes. 58, 1739-1748 (2009).
25. Burgess, K., Xu, T., Brown, R., Han, B., Welle, S. Effect of myostatin depletion on weight gain, hyperglycemia, and hepatic steatosis during five months of high-fat feeding in mice. PLoS One. 6, e17090 (2011).
26. van Dijk, R. A., Virmani, R., von der Thüsen, J. H., Schaapherder A. F., Lindeman, J. H. The natural history of aortic atherosclerosis: A systematic histopathological evaluation of the peri-renal region. Atherosclerosis. 210, 100-106 (2010).
27. Lee, Y. S., Huynh, T. V., Lee, S. J. Paracrine and endocrine modes of myostatin action. J Appl Physiol (1985). 120, 592-598 (2016).
28. Niessen, P., et al. Biochemical evidence for interaction between smoothelin and filamentous actin. Exp Cell Res. 292, 170-178 (2004).
29. Rensen, S. S., Doevendans, P. A., van Eys, G. J. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth Heart J. 15, 100-108 (2007).
30. Huang, Z., Chen, X., Chen, D. Myostatin: A novel insight into its role in metabolism, signal pathways, and expression regulation. Cell Signal. 23, 1441-1446 (2011).
31. Maiellaro, K., Taylor, W. R. The role of the adventitia in vascular inflammation. Cardiovasc Res. 75, 640-648 (2007).
32. Branchetti, E., et al. Oxidative stress modulates vascular smooth muscle cell phenotype via CTGF in thoracic aortic aneurysm. Cardiovasc Res. 100, 316-324 (2013).
33. Rodríguez, A. I., et al. MEF2B-Nox1 signaling is critical for stretch-induced phenotypic modulation of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 35, 430-438 (2015).
34. Rensen, S. S., et al. Smoothelin-B deficiency results in reduced arterial contractility, hypertension, and cardiac hypertrophy in mice. Circulation. 118, 828-836 (2008).
35. van der Loop, F. T., Gabbiani, G., Kohnen, G., Ramaekers, F. C., van Eys, G. J. Differentiation of smooth muscle cells in human blood vessels as defined by smoothelin, a novel marker for the contractile phenotype. Arterioscler Thromb Vasc Biol. 17, 665-671 (1997).
36. Bish, L. T., Morine, K. J., Sleeper, M. M., Sweeney, H. L. Myostatin is upregulated following stress in an Erk-dependent manner and negatively regulates cardiomyocyte growth in culture and in a mouse model. PLoS One. 5, e10230 (2010).
37. McKoy, G., Bicknell, K. A., Patel, K., Brooks, G. Developmental expression of myostatin in cardiomyocytes and its effect on foetal and neonatal rat cardiomyocyte proliferation. Cardiovascular Research 74, 304-312 (2007).
38. Tojkander, S., Gateva, G., Lappalainen P. Actin stress fibers-assembly, dynamics and biological roles. J Cell Sci. 125, 1855-1864 (2012).
39. Peiris, H. N., et al. Myostatin is localized in extravillous trophoblast and up-regulates migration. J Clin Endocrinol Metab. 99, E2288-E2297 (2014).
40. Bennett, M. R., Evan, G. I., Schwartz, S. M. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest. 95, 2266-2274 (1995).
41. Janjanam, J., Chandaka, G. K., Kotla, S., Rao, G. N. PLC 3 mediates cortactin interaction with WAVE2 in MCP1-induced actin polymerization and cell migration. Mol Biol Cell. 26, 4589-4606 (2015).
42. Orlandi, A., Bennett, M. Progenitor cell-derived smooth muscle cells in vascular disease. Biochem Pharmacol. 79, 1706-1713 (2010).
43. Simper, D., Stalboerger, P. G., Panetta, C. J., Wang, S., Caplice, N. M. Smooth muscle progenitor cells in human blood. Circulation. 106, 1199-1204 (2002).
44. Yu, H., et al. Bone marrow-derived smooth muscle-like cells are infrequent in advanced primary atherosclerotic plaques but promote atherosclerosis. Arterioscler Thromb Vasc Biol. 31, 1291-1299 (2011).
45. Gomez, D., Owens, G. K. Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc Res. 95, 156-164 (2012).
46. Wrigley, B. J., Shantsila, E., Tapp, L. D., Lip, G. Y. CD14+ + CD16+ monocytes in patients with acute ischaemic heart failure. Eur J Clin Invest. 43, 121-130 (2013).
47. Johnsen, S. H., Forsdahl, S. H., Singh, K., Jacobsen, B. K. Atherosclerosis in abdominal aortic aneurysms: A causal event or a process running in parallel The Tromsø study. Arterioscler Thromb Vasc Biol. 30, 1263-1268 (2010).
48. Golledge, J., Norman, P. E. Atherosclerosis and abdominal aortic aneurysm: Cause, response, or common risk factors Arterioscler Thromb Vasc Biol. 30, 1075-1077 (2010).
49. Shi, N., Chen, S. Y. Smooth Muscle Cell Differentiation: Model Systems, Regulatory Mechanisms, and Vascular Diseases. J Cell Physiol. 231, 777-787 (2015).
50. Airhart, N., et al. Smooth muscle cells from abdominal aortic aneurysms are unique and can independently and synergistically degrade insoluble elastin. J Vasc Surg. 60, 1033-1041 (2014).
51. Majesky, M. W. Vascular Smooth Muscle Cells. Arterioscler Thromb Vasc Biol. 36, e82-e86 (2016).
52. Yang, J., et al. Adiponectin promotes monocyte-to-fibroblast transition in renal fibrosis. J Am Soc Nephrol. 24, 1644-1659 (2013).
53. Biesemann, N., et al. Myostatin induces interstitial fibrosis in the heart via TAK1 and p38. Cell Tissue Res. 361, 779-87 (2015).
54. Huang, Z., et al. Regulation of myostatin signaling by c-Jun N-terminal kinase in C2C12 cells. Cell Signal. 19, 2286-2295 (2007).
55. Verzola, D., et al. Enhanced glomerular Toll-like receptor 4 expression and signaling in patients with type 2 diabetic nephropathy and microalbuminuria. Kidney Int. 86, 1229-1243 (2014).
56. Ottonello, L., Bertolotto, M., Montecucco, F., Dapino, P., Dallegri F. Dexamethasone-induced apoptosis of human monocytes exposed to immune complexes. Intervention of CD95-A nd XIAP-dependent pathways. Int J Immunopathol Pharmacol. 18, 403-415 (2005).